Biotech Portfolio Companies

10x Genomics makes instruments, consumables and software for single-cell and spatial biology research. It went public on Nasdaq (TXG) in September 2019 and reported $642.8 million of revenue for 2025.

A San Diego biotech company using AI to accelerate drug discovery and development processes.

Boston-based biotech company developing analytics and data solutions for the life sciences industry.

Cambridge-based biotech company developing advanced analytics solutions for life sciences applications.

A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.

A Boston biotech company focused on biological flow systems and dynamics technologies, with $32M in Series A funding.

A San Diego biotech company focused on biological genesis and creation processes, backed by $42M in Series A funding.

An early-stage Cambridge biotech company serving as a nexus in the biopharmaceutical industry with $2.8M pre-seed funding.

A Basel-based regenerative medicine company with $150M in Series C funding, developing advanced regenerative therapies and technologies.

Alphabet's research and development biotech company focused on aging and longevity research.

Biotechnology company developing enzymatic DNA synthesis technology to enable on-demand, decentralized production of synthetic DNA for research and therapeutics.

Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.

Clinical-stage biotechnology company developing oral therapies that modulate the gut microbiome to treat inflammatory diseases.

Biopharmaceutical company focused on developing therapies for fibrotic diseases, anemia, and cancer through innovative drug discovery.

Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.

Gilgamesh Pharmaceuticals is a pharmaceutical company that is developing psychedelic and related drugs as medicines.

Ginkgo Bioworks is a Boston synthetic biology company that engineers cells for customers. It went public on the NYSE as DNA in September 2021 through a merger with Soaring Eagle Acquisition Corp.

Guardant Health develops blood-based liquid biopsy tests for cancer, led by Guardant360. It went public on Nasdaq as GH in October 2018 after raising about $550 million privately.

Biotechnology company developing protein engineering and synthetic biology platforms for drug discovery and development.

Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

Develops AI models for analyzing biological systems across multiple scales, from molecular to organism levels.

A Cambridge-based biotech company developing neurological therapeutics and treatments.

Veracyte is a South San Francisco genomic diagnostics company whose tests cover thyroid, prostate, breast and lung cancer. It went public on Nasdaq (VCYT) in October 2013 and reported $517M in revenue for 2025.